Stock CANF CAN-FITE BIOPHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Can-Fite BioPharma Ltd. Nyse

Equities

CANF

US13471N1028

End-of-day quote Nyse
Other stock markets
 23:00:00 04/02/2024 GMT 		5-day change 1st Jan Change
2.02 USD -3.35% Intraday chart for Can-Fite BioPharma Ltd. -4.04% -8.18%
06-10 Can-Fite Biopharma Ltd. Receives IRB Approval for the Treatment of Pancreatic Cancer with Namodenoson in a Phase IIa Study CI
06-06 Transcript : Can-Fite BioPharma Ltd. - Special Call

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Yossi Borenstein, CEO and Founder of Shizim Group, has been Elected to the Can-Fite Board
CI
Can-Fite Biopharma Ltd. Announces Board Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CANF Stock
  4. CANF Stock
  5. News Can-Fite BioPharma Ltd.
  6. Insiders
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW